Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Martine, Ffrench"'
Autor:
Lucile Baseggio, Alexandra Traverse-Glehen, Florence Petinataud, Evelyne Callet-Bauchu, Françoise Berger, Martine Ffrench, Chantal Marie Couris, Catherine Thieblemont, Dominique Morel, Bertrand Coiffier, Gilles Salles, Pascale Felman
Publikováno v:
Haematologica, Vol 95, Iss 4 (2010)
Background Classically, splenic marginal zone B-cell lymphoma is characterized by the absence of CD5 expression. Cases of apparent splenic marginal zone B-cell lymphoma showing CD5 expression, as diagnosed by blood studies, have been described; howev
Externí odkaz:
https://doaj.org/article/e16a37bcfc82450a825a059d6450227c
Autor:
Françoise Berger, Pascale Felman, Sandrine Hayette, Martine Ffrench, Laurent Jallades, Bertrand Coiffier, Evelyne Callet-Bauchu, Kaddour Chabane, Aurélie Verney, Sophie Gazzo, Gilles Salles, Alexandra Traverse-Glehen, Lucile Baseggio
Publikováno v:
Leukemia & lymphoma
Leukemia & lymphoma, Taylor & Francis, 2017, 58, pp.666-675. 〈10.1080/10428194.2016.1196813〉
Leukemia & lymphoma, Taylor & Francis, 2017, 58, pp.666-675. ⟨10.1080/10428194.2016.1196813⟩
Europe PubMed Central
Leukemia & lymphoma, Taylor & Francis, 2017, 58, pp.666-675. 〈10.1080/10428194.2016.1196813〉
Leukemia & lymphoma, Taylor & Francis, 2017, 58, pp.666-675. ⟨10.1080/10428194.2016.1196813⟩
Europe PubMed Central
International audience; Splenic Diffuse Red Pulp Lymphoma (SDRPL) has been recently introduced as a provisional entity but differential diagnosis with other splenic lymphomas is needed to be clarified since the therapeutic approaches are distinct. Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff01b1848c928eebf2b08321cbe3ab94
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01795706
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01795706
Autor:
Régine Catallo, Anne-Sophie Michallet, Olivier Roualdes, Jean-Pierre Magaud, Lucile Baseggio, Amel Chebel, Martine Ffrench, Gilles Salles, Delphine Manzoni
Publikováno v:
Leukemia Research
Leukemia Research, 2016, 47, pp.1--7. 〈10.1016/j.leukres.2016.05.003〉
Leukemia Research, Elsevier, 2016, 47, pp.1--7. ⟨10.1016/j.leukres.2016.05.003⟩
Leukemia Research, 2016, 47, pp.1--7. 〈10.1016/j.leukres.2016.05.003〉
Leukemia Research, Elsevier, 2016, 47, pp.1--7. ⟨10.1016/j.leukres.2016.05.003⟩
International audience; New B-cell receptor-targeted therapies such as ibrutinib, a Bruton tyrosine kinase inhibitor, are now proposed for lymphoid pathologies. The putative benefits of its combination with glucocorticoids were evaluated here. We com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4c01518e75b611661e11d9523de995a
https://hal.archives-ouvertes.fr/hal-01812695
https://hal.archives-ouvertes.fr/hal-01812695
Autor:
Olivier Hermine, Philippe Gaulard, Paul Mondière, Martine Ffrench, Thierry Defrance, Mitchell Kronenberg, Tayla Heavican, Laurent Genestier, Archana Khurana, Rémy Robinot, Alexandra Traverse-Glehen, Marco Herling, Thierry Lamy, Nadine Martin, Emmanuel Bachy, Javeed Iqbal, Mikael Roussel, Mirjam Urb, Gabriel Bricard, Lucile Baseggio, Shilpi Chandra, Simon de Bernard, Laurent Buffat, Patrice N. Marche, Gilles Salles, Vahid Asnafi, Joël Lachuer, Alexandra Schrader, Olivier Blond, Stéphane Dalle, Olivier Thaunat, Sophie Gazzo, Giuliano Crispatzu, Morgan Taillardet, Magali Le Garff-Tavernier
Publikováno v:
Journal of Experimental Medicine
Journal of Experimental Medicine, Rockefeller University Press, 2016, 213 (5), pp.841-57. ⟨10.1084/jem.20150794⟩
Journal of Experimental Medicine, 2016, 213 (5), pp.841-57. ⟨10.1084/jem.20150794⟩
The Journal of Experimental Medicine
Journal of Experimental Medicine, 2016, 213 (5), pp.841-57. 〈10.1084/jem.20150794〉
Journal of Experimental Medicine, Rockefeller University Press, 2016, 213 (5), pp.841-857. <10.1084/jem.20150794>
Journal of Experimental Medicine, Rockefeller University Press, 2016, 213 (5), pp.841-57. ⟨10.1084/jem.20150794⟩
Journal of Experimental Medicine, 2016, 213 (5), pp.841-57. ⟨10.1084/jem.20150794⟩
The Journal of Experimental Medicine
Journal of Experimental Medicine, 2016, 213 (5), pp.841-57. 〈10.1084/jem.20150794〉
Journal of Experimental Medicine, Rockefeller University Press, 2016, 213 (5), pp.841-857. <10.1084/jem.20150794>
Genestier et al. shed light on the cellular origin of peripheral T cell lymphoma (PTCL), showing that in both mice and humans, unconventional CD1d-restricted T cells may give rise to PTCL.
Peripheral T cell lymphomas (PTCLs) are a heterogeneous
Peripheral T cell lymphomas (PTCLs) are a heterogeneous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbb80293ce2f29bf2bc64e1540f2ccca
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01305487
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01305487
Autor:
Martine Ffrench, Sandrine Hayette, Alexandra Traverse-Glehen, Laurent Jallades, Jean-Pierre Magaud, Aurélie Verney, Françoise Berger, Lucile Baseggio, Marie-Odile Geay, Gilles Salles, Sophie Gazzo, Pascale Felman, Evelyne Callet-Bauchu, Dominique Morel
Publikováno v:
British Journal of Haematology. 158:489-498
The translocation t(14;18) and its t(2;18) and t(18,22) variants, which involve the BCL2 genetic hallmark for follicular lymphoma (FL), have been reported in several cases of chronic B-cell lymphoproliferative disease (CLPD) and frequently in chronic
Autor:
Domenech C, Jean-Pierre Magaud, Gilles Salles, Régine Catallo, Martine Ffrench, Wei Wen Chien, Kaddar T
Publikováno v:
Oncogene. 30:1880-1891
The p16(INK4a) protein regulates cell cycle progression mainly by inhibiting the activity of G1-phase cyclin-dependent kinases (CDKs) 4 and 6, the subsequent retinoblastoma protein (pRb) phosphorylation and E2F transcription factor release. The p16(I
Autor:
Martine Ffrench, Amel Chebel
Publikováno v:
Transcription. 1:27-31
hTERT and NFAT were thought until recently to belong to separate metabolic compartments. The involvement of NFAT in the induction of hTERT transcription, suggested by hTERT expression variations during lymphocyte stimulation and immunosuppressive tre
Autor:
Françoise Berger, Catherine Chassagne-Clément, Florence Broussais-Guillaumot, Evelyne Callet-Bauchu, Catherine Sebban, Hervé Ghesquières, Gilles Salles, Jean-François Larouche, Bertrand Coiffier, Martine Ffrench
Publikováno v:
Journal of Clinical Oncology. 28:2094-2100
Purpose Patients with diffuse large B-cell lymphoma (DLBCL) usually relapse early following diagnosis but some relapses happen at 5 years or later. Few data exist regarding clinical characteristics and outcome of these patients. Patients and Methods
Autor:
Martine Ffrench, Luc-Marie Gerland, Régine Catallo, Eric Gilson, Yves Tourneur, Aude Roborel de Climens, Serge Bauwens, Iwona Urbanowicz, Gilles Salles, Aurélie Belleville, Amel Chebel, Wei Wen Chien
Publikováno v:
Aging Cell. 8:52-64
Normal lymphocytes represent examples of somatic cells that are able to induce telomerase activity when stimulated. As previously reported, we showed that, during lymphocyte long-term culture and repeated stimulations, the appearance of senescent cel
Autor:
Martine Ffrench, Catherine Thieblemont, Pascale Felman, Gilles Salles, Evelyne Callet-Bauchu, Bertrand Coiffier, Aurélie Verney, Alexandra Traverse-Glehen, Françoise Berger, Jean-Pierre Magaud, Lucile Baseggio
Publikováno v:
Leukemia. 21:1821-1824
Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin